Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome

KJ Bosma, JF Lewis - Expert Opinion on Emerging Drugs, 2007 - Taylor & Francis
Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a life-threatening form of
respiratory failure that affects a heterogeneous population of critically ill patients. Although …
被引用次数：77 相关文章

Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome.

KJ Bosma, JF Lewis - Expert Opinion on Emerging Drugs, 2007 - europepmc.org
Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a life-threatening form of
respiratory failure that affects a heterogeneous population of critically ill patients. Although …

[引用][C] Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome

KJ Bosma, JF Lewis - Expert Opinion on Emerging Drugs, 2007 - cir.nii.ac.jp
Emerging therapies for treatment of acute lung injury and acute respiratory distress
syndrome | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome

KJ Bosma, JF Lewis - Expert opinion on emerging drugs, 2007 - pubmed.ncbi.nlm.nih.gov
Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a life-threatening form of
respiratory failure that affects a heterogeneous population of critically ill patients. Although …

Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome

KJ Bosma, JF Lewis - Expert Opinion on Emerging Drugs, 2007 - hero.epa.gov
Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a life-threatening form of
respiratory failure that affects a heterogeneous population of critically ill patients. Although …